Cellular Forte
100/100
This product looks safe
- No ingredients exceed tolerable upper intake levels
- 50% of ingredients have research evidence
A
Label Compliance Grade
Product Label
Have a supplement label? Find it here.
Upload a photo of any supplement label to search our database of 92,312 products.
Label Data
2 Capsule(s)
Serving Size
120
Servings
Non-Nutrient/Non-Botanical
Product Type
50%
Evidence Coverage
Supplement Facts — Evidence Check
Total Carbohydrate
1 Gram(s)
(1% DV)
Calcium
131 mg
(10% DV)
192 mg
(15% DV)
✅ Within RDA (0.3× RDA of 700 mg)
📚 12 studies (Tier A: 0, B: 3)
40 mg
(10% DV)
📊 Market median: 4002.0mg (1 products)
📚 20 studies (Tier A: 0, B: 2)
IP-6
800 mg
220 mg
📊 Market median: 550.0mg (217 products)
📚 29 studies (Tier A: 0, B: 5)
Other Ingredients
Cellulose
Hypromellose
Magnesium Stearate
Label Claims — Verification
❓
All Other
❓
Structure/Function
All Other (98% of products)
Structure/Function (89% of products)
Nutrient (76% of products)
Target Groups
Vegan
Vegetarian
Adult (18 - 50 Years)
Gluten Free
Dairy Free
Product Information
📋 Directions for Use
Recommendation: Adults take 2 capsules twice daily. Best taken on an empty stomach.
⚠️ Warnings & Precautions
Keep out of reach of children.
Safety sealed with inner seal. Do not use if seal is broken or missing.
If you are pregnant, nursing, or taking any medications, consult a healthcare professional before use.
🧪 Formulation Notes
Vegan
Contains no wheat, gluten, soy, dairy, or artificial colors, or flavors.
With IP-6 and Inositol
Additional Information
For more information, please visit integrativepro.com.
Keep tightly closed. Store at room temperature. Avoid excessive heat and direct sunlight.
Quality Global Sourcing Bottled & Tested in the USA
Product Details
UPC / SKU
8 71791 00098 8
DSLD Entry Date
2023-06-22
Product Type
Non-Nutrient/Non-Botanical
Form
Capsule
Brand
Integrative Therapeutics
DSLD ID
292739
Data Updated
2026-04-11
Research Evidence
46
Research Sources
55
Avg Quality Score
23
Meta Analysis
7
Systematic Review
7
Rct
4
Clinical Trial
2
Other
1
Guideline
1
Regulatory Source
A
Phosphate binders for preventing and treating chronic kidney disease-mineral and bone disorder (CKD-MBD)
A
Phosphate binders for preventing and treating chronic kidney disease-mineral and bone disorder (CKD-MBD)
B
Phosphate binders for preventing and treating bone disease in chronic kidney disease patients
B
Radiographic and clinical outcomes of silicate-substituted calcium phosphate (SiCaP) bone grafts in spinal fusion: Systematic review and meta-analysis
B
ESPGHAN/ESPEN/ESPR/CSPEN guidelines on pediatric parenteral nutrition: Calcium, phosphorus and magnesium.
B
Effect of different phosphate binders on fibroblast growth factor 23 levels in patients with chronic kidney disease: a systematic review and meta-analysis of randomized controlled trials
B
The impact of phosphate lowering agents on clinical and laboratory outcomes in chronic kidney disease patients: a systematic review and meta-analysis of randomized controlled trials
Compare Similar Products
Uridine Monophosphate Capsules 250 mg
Nootropics Depot
100
IP-6
Wonder Laboratories
100
Calcium Phosphorus
Wonder Laboratories
100
Calcium Phosphorus
Wonder Laboratories
100
Calcium Phosphorus
Wonder Laboratories
100